HomeCompareXRPC vs MRK

XRPC vs MRK: Dividend Comparison 2026

XRPC yields 13.99% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $6.6K in total portfolio value· pulled ahead in Year 10
10 years
XRPC
XRPC
● Live price
13.99%
Share price
$14.30
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$50.1K
Annual income
$3,327.79
Full XRPC calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — XRPC vs MRK

📍 MRK pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodXRPCMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, XRPC + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
XRPC pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XRPC
Annual income on $10K today (after 15% tax)
$1,188.81/yr
After 10yr DRIP, annual income (after tax)
$2,828.62/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $5,499.79/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XRPC + MRK for your $10,000?

XRPC: 50%MRK: 50%
100% MRK50/50100% XRPC
Portfolio after 10yr
$53.5K
Annual income
$6,562.97/yr
Blended yield
12.28%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

XRPC
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XRPC buys
0
MRK buys
0
No recent congressional trades found for XRPC or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricXRPCMRK
Forward yield13.99%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$50.1K$56.8K
Annual income after 10y$3,327.79$9,798.13
Total dividends collected$23.2K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: XRPC vs MRK ($10,000, DRIP)

YearXRPC PortfolioXRPC Income/yrMRK PortfolioMRK Income/yrGap
1$12,099$1,398.60$11,206$366.19+$893.00XRPC
2$14,527$1,581.41$12,650$502.35+$1.9KXRPC
3$17,318$1,774.60$14,407$694.19+$2.9KXRPC
4$20,508$1,977.20$16,585$967.82+$3.9KXRPC
5$24,132$2,188.16$19,342$1,363.89+$4.8KXRPC
6$28,227$2,406.36$22,913$1,947.19+$5.3KXRPC
7$32,834$2,630.62$27,662$2,823.89+$5.2KXRPC
8$37,992$2,859.75$34,159$4,173.35+$3.8KXRPC
9$43,744$3,092.53$43,337$6,308.80+$407.00XRPC
10← crossover$50,134$3,327.79$56,776$9,798.13$6.6KMRK

XRPC vs MRK: Complete Analysis 2026

XRPCStock

XRPC seeks to provide direct exposure to the price of XRP, a decentralized digital asset designed for real-time payment and settlement via the XRP Ledger. All XRP tokens were created at launch in 2012. The calculation of the funds NAV is based on a benchmark provided by CoinDesk Indices, aggregating prices from major XRP trading platforms. XRP held by the Trust is stored at Gemini and BitGo, both private custodians insured by non-FDIC carriers. Unlike stocks or bonds, XRP ownership confers no company profits or income, and is only recorded on a decentralized ledger. The ETF advantage for investors is that they can access the market performance of XRP through their regular brokerage accounts, without needing to hold XRP directly or face related risks. The Trust does not use derivatives, loans, or leverage. The XRP Ledger uses a low-energy, consensus-based mechanism rather than mining, enabling fast, low-cost cross-border transactions.

Full XRPC Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this XRPC vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XRPC vs SCHDXRPC vs JEPIXRPC vs OXRPC vs KOXRPC vs MAINXRPC vs JNJXRPC vs ABBVXRPC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.